Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The serotonin receptor-ion channel complex, primarily referring to the 5-HT3 receptor, is a unique ligand-gated ion channel that mediates rapid excitatory neurotransmission. Upon serotonin binding, it opens a cation-selective pore, leading to neuronal depolarization. It plays a role in nausea/vomiting reflexes, gut motility, and modulation of pain pathways, with antagonists used as antiemetics.
Ligand binding opens a cation-selective pore, leading to neuronal depolarization and excitation.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serotonin Receptor-Ion Channel Complex (5-HT3 Receptor).